2020medRxivOpen access

Cohort profile: COVID-19 in a cohort of pregnant women and their descendants, the MOACC-19 study

Javier Llorca, Carolina Lechosa‐Muñiz, Pilar Gortázar, María Fernández-Ortiz, Yolanda Jubete, María Jesús Cabero, the MOACC-19 group, Jéssica Alonso-Molero, Bárbara Arozamena, Laura Conde-Gil, Elsa Cornejo del Río, Rocío Cuesta-González, Trinidad Dierssen‐Sotos, Pelayo Frank de Zulueta, Inés Gómez‐Acebo, Coral Llano-Ruiz, Lorena Lasarte-Oria, Sonia López-Gómez, Sonia Mateo-Sota, Victoria Orallo, Rosa Pardo, Daniel Pérez González, María Sáez de Adana Herrero

Open full text 0 citations

Abstract

ABSTRACT Purpose The Mother and Child Covid-19 study is a cohort recruiting pregnant women and their children in Cantabria, North of Spain, during COVID-19 pandemic in order to ascertain Consequences of SARS-CoV-2 infection on pregnant women and their descendants. This article reports the cohort profile and preliminary results as recruitment is still open. Participants Three sub-cohorts can be identified at recruitment. Sub-cohort 1 includes women giving birth between 23 rd March and 25 th May 2020; they have been retrospectively recruited and could have been exposed to COVID-19 only in their third trimester of pregnancy. Sub-cohort 2 includes women giving birth from 26 th May 2020 on; they are being prospectively recruited and could have been exposed to COVID-19 in both their second and third trimesters of pregnancy. Sub-cohort 3 includes women in their 12 th week of pregnancy prospectively recruited from 26 th May 2020 on; they could have been exposed to COVID-19 anytime in their pregnancy. All women are being tested for SARS-CoV-2 infection using both RT-PCR for RNA detection and ELISA for anti-SARS-CoV-2 antibodies. All neonates are being tested for antibodies using immunochemoluminiscency tests; if the mother is tested positive for SARS-CoV-2 RNA, a naso-pharyngeal swab is also obtained from the child for RT-PCR analysis. Findings to date As of 22 nd October, 1167 women have been recruited (266, 354 and 547 for sub-cohorts 1, 2 and 3, respectively). Fourteen women tested positive to SARS-CoV-2 RNA by the day of delivery. All fourteen children born from these women tested negative for SARS-CoV-2 RNA. Future plans Children from women included in sub-cohort 3 are expected to be recruited by the end of 2020. Children will be followed-up for one year in order to ascertain the effect that COVID-19 on their development. ARTICLE SUMMARY Strengths and limitations Strengths This cohort would ascertain the effect of COVID-19 in both mother and children whatever the trimester of the infection. It would also compare health care provided to pregnant women during the COVID-19 pandemic with that provided in the same hospital before the emergence of COVID-19. The cohort is recruited in Spain, one of the developed countries earlier and more affected by COVID-19. Limitations The study could be underpowered according to the prevalence reported in a Spanish national study. Information regarding exposure to people infected by SARS-CoV-2 or risk activities is self-reported.

Open-access reader

About this research paper

What this paper is about

ABSTRACT Purpose The Mother and Child Covid-19 study is a cohort recruiting pregnant women and their children in Cantabria, North of Spain, during COVID-19 pandemic in order to ascertain Consequences of SARS-CoV-2 infection on pregnant women and their descendants. This article reports the cohort profile and preliminary results as recruitment is still open. Participants Three sub-cohorts can be identified at recruitment. Sub-cohort 1 includes women giving birth between 23 rd March and 25 th May 2020; they have been retrospectively recruited and could have been exposed to COVID-19 only in their third trimester of pregnancy. Sub-cohort 2 includes women giving birth from 26 th May 2020 on; they are being prospectively recruited and could have been exposed to COVID-19 in both their second and third trimesters of pregnancy. Sub-cohort 3 includes women in their 12 th week of pregnancy prospectively recruited from 26 th May 2020 on; they could have been exposed to COVID-19 anytime in their pregnancy. All women are being tested for SARS-CoV-2 infection using both RT-PCR for RNA detection and ELISA for anti-SARS-CoV-2 antibodies. All neonates are being tested for antibodies using immunochemoluminiscency tests; if the mother is tested positive for SARS-CoV-2 RNA, a naso-pharyngeal swab is also obtained from the child for RT-PCR analysis. Findings to date As of 22 nd October, 1167 women have been recruited (266, 354 and 547 for sub-cohorts 1, 2 and 3, respectively). Fourteen women tested positive to SARS-CoV-2 RNA by the day of delivery. All fourteen children born from these women tested negative for SARS-CoV-2 RNA. Future plans Children from women included in sub-cohort 3 are expected to be recruited by the end of 2020. Children will be followed-up for one year in order to ascertain the effect that COVID-19 on their development. ARTICLE SUMMARY Strengths and limitations Strengths This cohort would ascertain the effect of COVID-19 in both mother and children whatever the trimester of the infection. It would also compare health care provided to pregnant women during the COVID-19 pandemic with that provided in the same hospital before the emergence of COVID-19. The cohort is recruited in Spain, one of the developed countries earlier and more affected by COVID-19. Limitations The study could be underpowered according to the prevalence reported in a Spanish national study. Information regarding exposure to people infected by SARS-CoV-2 or risk activities is self-reported.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

ABSTRACT Purpose The Mother and Child Covid-19 study is a cohort recruiting pregnant women and their children in Cantabria, North of Spain, during COVID-19 pandemic in order to ascertain Consequences of SARS-CoV-2 infection on pregnant women and their descendants. This article reports the cohort profile and preliminary results as recruitment is still open. Participants Three sub-cohorts can be identified at recruitment. Sub-cohort 1 includes women giving birth between 23 rd March and 25 th May 2020; they have been retrospectively recruited and could have been exposed to COVID-19 only in their third trimester of pregnancy. Sub-cohort 2 includes women giving birth from 26 th May 2020 on; they are being prospectively recruited and could have been exposed to COVID-19 in both their second and third trimesters of pregnancy. Sub-cohort 3 includes women in their 12 th week of pregnancy prospectively recruited from 26 th May 2020 on; they could have been exposed to COVID-19 anytime in their pregnancy. All women are being tested for SARS-CoV-2 infection using both RT-PCR for RNA detection and ELISA for anti-SARS-CoV-2 antibodies. All neonates are being tested for antibodies using immunochemoluminiscency tests; if the mother is tested positive for SARS-CoV-2 RNA, a naso-pharyngeal swab is also obtained from the child for RT-PCR analysis. Findings to date As of 22 nd October, 1167 women have been recruited (266, 354 and 547 for sub-cohorts 1, 2 and 3, respectively). Fourteen women tested positive to SARS-CoV-2 RNA by the day of delivery. All fourteen children born from these women tested negative for SARS-CoV-2 RNA. Future plans Children from women included in sub-cohort 3 are expected to be recruited by the end of 2020. Children will be followed-up for one year in order to ascertain the effect that COVID-19 on their development. ARTICLE SUMMARY Strengths and limitations Strengths This cohort would ascertain the effect of COVID-19 in both mother and children whatever the trimester of the infection. It would also compare health care provided to pregnant women during the COVID-19 pandemic with that provided in the same hospital before the emergence of COVID-19. The cohort is recruited in Spain, one of the developed countries earlier and more affected by COVID-19. Limitations The study could be underpowered according to the prevalence reported in a Spanish national study. Information regarding exposure to people infected by SARS-CoV-2 or risk activities is self-reported.

Key concepts: Cohort, Pregnancy, Medicine, Cohort study, Obstetrics, Coronavirus disease 2019 (COVID-19), Pandemic, Prospective cohort study

Related papers

Back to paper searchBrowse research topicsOriginal source
Cohort profile: COVID-19 in a cohort of pregnant women and their descendants, the MOACC-19 study — Research Paper | ScholarLens